3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Diabetes - Heart -

Heart care sub par in older diabetics: study

Diabetes • • HeartJul 11, 07

A low proportion of elderly individuals newly diagnosed with type 2 diabetes receive heart-protecting drugs like aspirin, blood pressure-lowering drugs and cholesterol-lowering drugs, according to a Canadian study.

People with diabetes are at increased risk for developing heart and vascular disease. The results of the current study suggest that the management of cardiovascular risk for type 2 diabetes patients is “less than appropriate,” the study team concludes in the journal Diabetes Care this month.

In a study of more than 12,000 patients, the researchers found that only about 22 percent received a heart-protecting anti-clotting drug like aspirin in the year after anti-diabetes medication was begun. Only about 40 percent received an antihypertensive and 21 percent received a cholesterol-lowering drug, the investigators report.

Only 7.6 percent received a comprehensive cardioprotective regimen including all three types of medication, they found.

“Treating a diabetic person is important. However, controlling (blood sugar) should not be the only treatment goal even in people aged 65 years or over,” study investigator Dr. Jean-Pierre Gregoire, from Laval University, Quebec City, told Reuters Health.

Gregoire suggested that doctors “may not be sufficiently aware of the benefits of treating elderly individuals with diabetes using cardioprotective medications. Given their life-expectancy, these individuals can also benefit from pharmacologic cardiovascular protection,” the researcher said.

“Elderly individuals with diabetes should also be sensitized to the fact that, relative to those who don’t suffer from diabetes, they have an increased cardiovascular risk,” Gregoire added.

He noted that the number of type 2 diabetics is likely to increase in this age group in the next decade. “If the actual situation continues to prevail, in the future the suboptimal use of medications in elderly type 2 diabetics may entail substantial healthcare resources,” Gregoire concluded.

SOURCE: Diabetes Care July 2007.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Implantable ‘artificial pancreas’ could help diabetes patients control their blood sugar
  Joslin researchers find drugs are effective for diabetic macular edema in new trial
  New superfoods could help key protein keep bodies healthy
  Mobile app on emergency cardiac care aids best decisions in seconds
  Train your heart to protect your mind
  Poor quality of life may affect teens’ diabetes management
  Mass. General study identifies path to safer drugs for heart disease, cancer
  Tweaking MRI to track creatine may spot heart problems earlier, Penn Medicine study suggests
  Cancer drug protects against diabetes
  Amino acid’s increase is suspected in diabetes
  New Type 2 Diabetes Drug Onglyza Approved
  Mail order pharmacy use safe for people with diabetes

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site